Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

PRospective Evaluation of Electrocardiographic Voltage Changes and Six Minute Walk Test for Predicting Readmissions in Heart Failure (PREEMT-HF Study) (PREEMT-HF)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01675544
Recruitment Status : Completed
First Posted : August 30, 2012
Results First Posted : September 29, 2014
Last Update Posted : November 30, 2015
Sponsor:
Information provided by (Responsible Party):
Creighton University

Brief Summary:
Purpose of the study: To identify whether Electrocardiographic QRS voltage changes (between admission and pre-discharge) and pre discharge 6- minute walk test in patients admitted with acute heart failure can identify patients at risk for recurrent admissions for heart failure.

Condition or disease Intervention/treatment
Heart Failure Procedure: Electrocardiogram Procedure: Six minute walk test

Detailed Description:

Primary Objective Determine the ability of EKG voltage changes and pre discharge 6-minute walk test (6-MWT) to predict repeat heart failure hospitalization (HFH) in patients admitted with acute decompensated heart failure (ADHF).

Secondary Objectives

  1. Determine the ability of EKG voltage changes and pre discharge 6-MWT) to predict a composite of 1 year mortality and HFH in patients admitted with ADHF.
  2. Determine the ability of proportionate pulse pressure, orthostatic blood pressure changes and pre discharge inferior vena cava (IVC) diameter by portable ultrasound to predict HFH and mortality

Layout table for study information
Study Type : Observational
Actual Enrollment : 46 participants
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : August 2012
Actual Primary Completion Date : June 2014
Actual Study Completion Date : June 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Failure

Group/Cohort Intervention/treatment
Heart Failure Admission
Patients admitted for acute decompensated heart failure
Procedure: Electrocardiogram
EKG voltage changes between admission and discharge
Other Name: EKG

Procedure: Six minute walk test
Other Name: 6-MWT




Primary Outcome Measures :
  1. Emergency Room Visit or Hospitalization for Acute Decompensated Heart Failure (ADHF) [ Time Frame: 1 year ]
  2. Mortality [ Time Frame: 1 year ]
    All cause mortality at 1 year



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   19 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients admitted with acute decompensated heart failure
Criteria

Inclusion Criteria:

  • Patients > 18 years of age, admitted with a diagnosis of ADHF and fulfilling the following criteria:

    1. Evidence of systemic congestion (manifested by any 2 of the following criteria: jugular venous distension, edema, pulmonary rales, Left ventricular S3, or radiographic evidence of pulmonary venous congestion)
    2. Elevated Brain natriuretic peptide
    3. Need for at least 1 dose of intravenous loop diuretic

Exclusion Criteria:

  • Cardiogenic shock, Acute coronary syndromes (patients with mild elevation in troponin related to heart failure will not be excluded), patients who are admitted for another principal problem and develop ADHF in the hospital, pregnant females, end stage renal disease on hemodialysis, expected survival < 6 months.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01675544


Locations
Layout table for location information
United States, Nebraska
Creighton University Medical Center
Omaha, Nebraska, United States, 68131
Sponsors and Collaborators
Creighton University
Investigators
Layout table for investigator information
Principal Investigator: Venkata M Alla, MBBS Creighton University
Layout table for additonal information
Responsible Party: Creighton University
ClinicalTrials.gov Identifier: NCT01675544    
Other Study ID Numbers: 12-16350
First Posted: August 30, 2012    Key Record Dates
Results First Posted: September 29, 2014
Last Update Posted: November 30, 2015
Last Verified: November 2015
Keywords provided by Creighton University:
Heart failure
Additional relevant MeSH terms:
Layout table for MeSH terms
Heart Failure
Heart Diseases
Cardiovascular Diseases